Table 4.
Clinical Outcomes of Study Participants by Hyperuricemia Status
| Characteristics | Normal Uric Acid | Hyperuricemia | Crude OR (95% CI) | Adjusteda OR (95% CI) |
|---|---|---|---|---|
| (n=440, 75%) | (n=145, 25%) | |||
| Hypertension | 181 (41.1) | 86 (59.3) | 2.09 (1.42–3.05) | 2.20 (1.41–3.47) |
| High WC | 149 (33.9) | 59 (40.7) | 1.34 (0.91–1.97) | 1.67 (1.05–2.65) |
| Diabetes | 23 (5.2) | 9 (6.2) | 1.20 (0.54–2.65) | 1.17 (0.49–2.55) |
| Dyslipidemia | 268 (60.9) | 91 (62.8) | 1.08 (0.73–1.59) | 1.07 (0.72–1.60) |
| Overweight | 120 (27.3) | 50 (34.5) | 1.40 (0.94–2.09) | 1.42 (0.95–2.14) |
| Obesity | 82 (18.6) | 33 (22.7) | 1.29 (0.81–2.03) | 1.32 (0.81–2.13) |
| Smoking | 24 (5.4) | 11 (7.6) | 1.42 (0.68–2.98) | 1.25 (0.56–2.60) |
| Metabolic syndrome | 108 (24.5) | 49 (33.8) | 1.57 (1.04–2.36) | 1.66 (1.07–2.57) |
Abbreviations: CI, confidence interval; OR, odds ratio; WC, waist circumference. Values are expressed as number (percentage). Chi‐square test. Hyperuricemia was defined as serum urate levels >7.0 mg/dL in men and >5.7 mg/dL in women, according to National Health and Nutrition Examination Survey criteria.
a
The model was adjusted for age and sex.